NIH Awards $37M for SEER Program Surveillance and Research to University of California, San Francisco

Contract Overview

Contract Amount: $36,929,919 ($36.9M)

Contractor: Regents of the University of California, SAN Francisco, the

Awarding Agency: Department of Health and Human Services

Start Date: 2018-08-03

End Date: 2026-04-30

Contract Duration: 2,827 days

Daily Burn Rate: $13.1K/day

Competition Type: FULL AND OPEN COMPETITION

Number of Offers Received: 1

Pricing Type: COST SHARING

Sector: R&D

Official Description: NOVATION FROM CPIC TO UCSF EFFECT. 8/01/18--SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM, POP: 05/01/2018-04/30/2028

Place of Performance

Location: SAN FRANCISCO, SAN FRANCISCO County, CALIFORNIA, 94103

State: California Government Spending

Plain-Language Summary

Department of Health and Human Services obligated $36.9 million to REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE for work described as: NOVATION FROM CPIC TO UCSF EFFECT. 8/01/18--SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM, POP: 05/01/2018-04/30/2028 Key points: 1. Contract awarded for surveillance, epidemiology, and end results (SEER) program. 2. Long-term contract (2018-2028) with a total value of $36.9M. 3. Competition method was full and open, suggesting potential for competitive pricing. 4. Sector is Research and Development, a critical area for public health advancement.

Value Assessment

Rating: good

The contract value of $36.9M over 10 years averages approximately $3.7M annually. This appears reasonable for a large-scale national program like SEER, but a direct comparison to similar surveillance programs would be needed for a definitive assessment.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

The contract was awarded through full and open competition, which typically fosters competitive pricing and ensures the government receives the best value. The award process likely involved multiple bids, allowing for price discovery.

Taxpayer Impact: The SEER program provides crucial data for cancer research and public health initiatives, making this investment a valuable use of taxpayer funds for improving health outcomes.

Public Impact

Supports vital cancer research and public health monitoring through the SEER program. Ensures continuity of data collection and analysis for cancer trends. Benefits patients and healthcare providers through improved understanding of cancer. Contributes to evidence-based policy decisions in cancer prevention and treatment.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Potential for cost overruns in long-term research contracts.
Reliance on a single awardee for a critical national program.

Positive Signals

Awarded through full and open competition.
Supports a program with significant public health impact.
Long-term contract provides stability for research continuity.

Sector Analysis

The Research and Development sector, particularly in physical, engineering, and life sciences, is a significant area of federal spending. This contract aligns with NIH's mission to support biomedical research, with annual spending benchmarks varying widely based on the specific research area and scope.

Small Business Impact

The data indicates this contract was awarded to the Regents of the University of California, San Francisco, a large research institution. There is no explicit indication of small business participation in this specific award, which is common for large-scale research grants and contracts.

Oversight & Accountability

The National Institutes of Health (NIH) is responsible for overseeing this contract. Standard oversight mechanisms for research grants and contracts would apply, including progress reports and financial reviews, to ensure accountability and effective use of funds.

Related Government Programs

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Department of Health and Human Services Contracting
National Institutes of Health Programs

Risk Flags

Long-term contract duration may increase risk of cost escalation.
Potential for vendor lock-in if successor contracts are not competitively procured.
Reliance on a single entity for critical national data collection.
Changes in federal research priorities could impact program funding or scope.

Frequently Asked Questions

What is this federal contract paying for?

Department of Health and Human Services awarded $36.9 million to REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE. NOVATION FROM CPIC TO UCSF EFFECT. 8/01/18--SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM, POP: 05/01/2018-04/30/2028

Who is the contractor on this award?

The obligated recipient is REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE.

Which agency awarded this contract?

Awarding agency: Department of Health and Human Services (National Institutes of Health).

What is the total obligated amount?

The obligated amount is $36.9 million.

What is the period of performance?

Start: 2018-08-03. End: 2026-04-30.

What is the specific methodology used by the SEER program to collect and analyze cancer data, and how does this contract ensure the continuation and enhancement of these methods?

The SEER program collects data from population-based cancer registries across the US. This contract likely supports the ongoing data collection, quality control, and analytical processes. Enhancements may involve adopting new data sources, improving statistical methods, or developing advanced visualization tools to better understand cancer trends and inform public health strategies.

What are the key performance indicators (KPIs) for this contract, and how will the University of California, San Francisco's performance be measured against them to ensure program effectiveness?

Key performance indicators would likely include metrics related to data completeness, accuracy, timeliness of reporting, and the successful execution of planned research projects. Performance will be measured through regular progress reports, data quality audits, and the achievement of specific research milestones outlined in the contract deliverables.

Given the long duration of the contract, what provisions are in place to manage potential scope creep or adapt to evolving research needs and technological advancements in cancer surveillance?

Long-term contracts often include mechanisms for contract modifications or task orders to address evolving needs. Provisions may allow for adjustments to the scope of work based on scientific advancements or emerging public health priorities, subject to negotiation and approval, ensuring the program remains relevant and effective over its duration.

Industry Classification

NAICS: Professional, Scientific, and Technical Services › Scientific Research and Development Services › Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Product/Service Code: RESEARCH AND DEVELOPMENT › N – Health R&D Services

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION

Solicitation Procedures: SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY

Solicitation ID: N01PC6500374

Offers Received: 1

Pricing Type: COST SHARING (T)

Evaluated Preference: NONE

Contractor Details

Address: 1855 FOLSOM ST STE 420, SAN FRANCISCO, CA, 94103

Business Categories: Category Business, Educational Institution, Government, Higher Education, U.S. National Government, Not Designated a Small Business, Higher Education (Public), U.S. Regional/State Government

Financial Breakdown

Contract Ceiling: $49,138,339

Exercised Options: $36,929,919

Current Obligation: $36,929,919

Actual Outlays: $22,190,593

Contract Characteristics

Commercial Item: COMMERCIAL PRODUCTS/SERVICES PROCEDURES NOT USED

Cost or Pricing Data: NO

Parent Contract

Parent Award PIID: 75N91018D00032

IDV Type: IDC

Timeline